CN1190593A - Medicine for the treatment of rheumatism and arthritis - Google Patents

Medicine for the treatment of rheumatism and arthritis Download PDF

Info

Publication number
CN1190593A
CN1190593A CN98110035A CN98110035A CN1190593A CN 1190593 A CN1190593 A CN 1190593A CN 98110035 A CN98110035 A CN 98110035A CN 98110035 A CN98110035 A CN 98110035A CN 1190593 A CN1190593 A CN 1190593A
Authority
CN
China
Prior art keywords
parts
radix
medicine
rheumatism
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN98110035A
Other languages
Chinese (zh)
Other versions
CN1074670C (en
Inventor
朱贵来
王庆菊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98110035A priority Critical patent/CN1074670C/en
Publication of CN1190593A publication Critical patent/CN1190593A/en
Application granted granted Critical
Publication of CN1074670C publication Critical patent/CN1074670C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention disclosed a kind of Chinese proprietary medicine for treating rheumatic arthritis and rheumatoid arthritis. It is prepared up by using root of Chinese clematis, fructus chaenomelis, Sichuan aconite root, pseudo-ginseng, large-is obvious and there is no toxic side effect.

Description

Medicine for the treatment of rheumatism and arthritis
The invention belongs to-medicine of kind of treatment rheumatism, rheumatoid arthritis, specifically is the expelling wind and removing dampness Chinese patent medicine that preparation of raw material forms with the Chinese herbal medicine.
Rheumatism, rheumatoid arthritis are a kind of obstinate commonly encountered diseases, do not have age-sex's branch; Western medicine adopts symptomatic treatment injection penicillin or hormone medicine more at present, oral aspirin, indometacin etc., with medicine time length health there is bigger infringement, cause anasarca, gastrointestinal irriate, and drug withdrawal is promptly recurred, and prescriptions of Chinese medicine does not have fixedly prescription yet, and is decoction, takes fried very inconvenient; Or adopt oral Fructus Chaenomelis Pilulae, anti-rheumatism sheet, Radix Tripterygii Wilfordii ball, rheumatism horse anter etc., because of medicine is single, curative effect is not good.
The object of the present invention is to provide a kind of antiinflammatory expelling wind and removing dampness, and have no side effect treatment rheumatism, rheumatoid Chinese patent medicine.
Solution of the present invention is based on motherland's Chinese medicine to rheumatism, the sick pathogenetic understanding of rheumatoid arthritis, the Therapeutic Principle, achieve with reference to modern pharmacological research, select expelling wind and removing dampness for use, strengthening spleen, tonifying kidney, blood-activating stasis-removing kind Chinese medicine reaches antiinflammatory and relieves the pain and remove the purpose of rheumatism, rheumatoid symptom.
Medicine for the treatment of rheumatism and arthritis of the present invention is to be made by the following portions by weight proportion raw material:
Radix Clematidis 6-18 part, Fructus Chaenomelis 12-20 part, Radix Aconiti 3-6 part, Radix Notoginseng 10-20 part, Radix Gentianae Macrophyllae 6-9 part, Cortex schizophragmatis integrifolii radicis 15-30 part.
The present invention adopts such scheme to treat rheumatism, rheumatoid arthritis is evident in efficacy, effective percentage 100%, and cure rate 85%, the analgesia blood circulation promoting and blood stasis dispelling is rapid, has no side effect taking convenience.
Drug action mechanism of the present invention is as follows:
Among the present invention, Radix Clematidis, hot, salty, warm; Return 12 warps, expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, softening the hard mass sending down the fishbone, detoxifcation, detumescence.Modern pharmacological research proves: the Main Ingredients and Appearance of Radix Clematidis is: in the Radix Pulsatillae lactone, sterol, saccharide, Saponin, phenols, amino acid salts, organic acid (see " Chinese medicine " Chengdu University of Traditional Chinese Medicine edit the 311st page).Fructus Chaenomelis, sour, warm; Go into liver, spleen channel, Shujin arm alive, detumescence relieves the pain; Modern pharmacological research proves that the Main Ingredients and Appearance of Fructus Chaenomelis is: Saponin, flower ketone glycoside have obvious detumescence effect (seeing " Chinese country doctor's teaching material " People's Health Publisher, the 98th page) to arthritis.Radix Aconiti, is apt to into through arm the cold-damp of dispeling the wind numbness, severe and migratory arthralgia pain at hot, bitter, heat; Modern pharmacological research proof Radix Aconiti Main Ingredients and Appearance is: aconitine, and aconite secondary alkali, aconines etc. have analgesia, calmness, antiinflammatory action.(seeing the chief editor of " Chinese materia medica " Chengdu University of Traditional Chinese Medicine, the 306th page of Sichuan science tech publishing house).Radix Notoginseng, sweet, little hardship, temperature; Go into liver, bone, month intestinal warp, dissipating blood stasis hemostasis, reducing swelling and alleviating pain; Modern pharmacological research proves that the Radix Notoginseng Main Ingredients and Appearance is: arasaponin first, arasaponin second, arasaponin A, panaxatriol, panoxadiol, flavone, alkaloid (see the chief editor of " Chinese medicine " Chengdu University of Traditional Chinese Medicine etc. 352 pages).Radix Gentianae Macrophyllae, sweet, be slightly cold, go into stomach, liver and gall warp, wind-damp dispelling, reducing the asthenic fever, clearing away damp-heat, modern pharmacological research prove that the Main Ingredients and Appearance of Radix Gentianae Macrophyllae is: alkaloid (gentianin, second, third) saccharide; The Radix Gentianae Macrophyllae first is brought down a fever, analgesia, hypotensive effect.(seeing the chief editor of " Chinese medicine " Chengdu Chinese medicine university, the 309th page).Cortex schizophragmatis integrifolii radicis, sweet, little hardship, flat; Go into liver, spleen, stomach warp, the logical arm that dispels the wind, reinforcing waist and strengthening bone; Modern pharmacological research proves that the Main Ingredients and Appearance of Cortex schizophragmatis integrifolii radicis is: contain lactone (coumarin) phenols, aminoacid etc.; Can invigorating the liver and kidney, the strong stomach of waist (seeing the chief editor of " Chinese materia medica " Chengdu University of Traditional Chinese Medicine, the 330th page) by force.
All medicines share, and dispelling cold and removing dampness, blood circulation promoting and blood stasis dispelling, antipyretic-antalgic, benefiting qi and nourishing blood, strong muscles and bones increase body immunity, reach eliminating pathogenic factor for supporting vital QI, the arthritic purpose of vital QI recovered after pathogens eliminated treatment rheumatic and rheumatoid.
For showing the therapeutic effect of medicine of the present invention to rheumatism, rheumatoid, arthritis, through the clinical observation of 126 routine systems, and get medical history, patient's 46 examples that the state of an illness is suitable are organized in contrast, adopt the party regulation western medicine therapy, get 80 examples as test group, take medicine of the present invention and only obey once each 3 grams every day, the observation period is six months.
Adopt identical standard to add up at last, criterion of therapeutical effect is:
(1) symptom after taking medicine alleviates or disappearance person is considered as effectively immediately;
(2) sx need still to continue the pill taker for not healing;
(3) drug withdrawal is after 1 year, and the recidivist is not complete;
Table 1 matched group curative effect situation
Table 2 test curative effect situation:
Figure A9811003500051
Below in conjunction with embodiment the present invention is described in detail
Embodiment 1 get Radix Clematidis 16g, Fructus Chaenomelis 18g, Radix Aconiti 5g, Radix Notoginseng 18g, Radix Gentianae Macrophyllae 9g, Cortex schizophragmatis integrifolii radicis 26g go clean shine extremely dried, pulverize powdery powder more jointly, incapsulate, each 1g promptly makes wooden invention expelling wind and removing dampness medicine, obey once oral every day sleep evening before clothes three, got final product in six months.
Embodiment 2 gets Radix Clematidis 10g, Fructus Chaenomelis 15g, Radix Aconiti 4g, Radix Notoginseng 15g, Radix Gentianae Macrophyllae 8g, Cortex schizophragmatis integrifolii radicis 20g, and the method for making instructions about how to take medicine cure mainly rheumatoid, rheumatic arthritis merging contracture articular instability modification patient with implementing 1.
Embodiment 3 gets Radix Clematidis 6g, Fructus Chaenomelis 12g, Radix Aconiti 3g, Radix Notoginseng 10g, Radix Gentianae Macrophyllae 7g, Cortex schizophragmatis integrifolii radicis 16g, and method cures mainly rheumatism, the concurrent interior moist cardiac of arthritis with implementing 1.

Claims (4)

1, Medicine for the treatment of rheumatism and arthritis is characterized in that it is the medicament of being made by the following portions by weight proportion raw material.
Radix Clematidis 6-18 part, Fructus Chaenomelis 12-20 part, Radix Aconiti 3-6 part, Radix Notoginseng 10-20 part, Radix Gentianae Macrophyllae 6-9 part, Cortex schizophragmatis integrifolii radicis 15-30 part.
2, Medicine for the treatment of rheumatism and arthritis according to claim 1, wherein each raw materials in part by weight proportioning is:
16 parts of Radix Clematidis, 18 parts of Fructus Chaenomeliss, 5 parts of Radix Aconitis, 18 parts of Radix Notoginseng, 9 parts of Radix Gentianae Macrophyllae, 26 parts of Cortex schizophragmatis integrifolii radiciss.
3, Medicine for the treatment of rheumatism and arthritis according to claim 1, wherein each raw materials in part by weight proportioning is:
10 parts of Radix Clematidis, 15 parts of Fructus Chaenomeliss, 4 parts of Radix Aconitis, 15 parts of Radix Notoginseng, 8 parts of Radix Gentianae Macrophyllae, 20 parts of Cortex schizophragmatis integrifolii radiciss.
4, Medicine for the treatment of rheumatism and arthritis according to claim 1, wherein each raw materials in part by weight proportioning is:
6 parts of Radix Clematidis, 12 parts of Fructus Chaenomeliss, 3 parts of Radix Aconitis, 10 parts of Radix Notoginseng, 7 parts of Radix Gentianae Macrophyllae, 16 parts of Cortex schizophragmatis integrifolii radiciss.
CN98110035A 1998-01-23 1998-01-23 Medicine for the treatment of rheumatism and arthritis Expired - Fee Related CN1074670C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98110035A CN1074670C (en) 1998-01-23 1998-01-23 Medicine for the treatment of rheumatism and arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98110035A CN1074670C (en) 1998-01-23 1998-01-23 Medicine for the treatment of rheumatism and arthritis

Publications (2)

Publication Number Publication Date
CN1190593A true CN1190593A (en) 1998-08-19
CN1074670C CN1074670C (en) 2001-11-14

Family

ID=5220128

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98110035A Expired - Fee Related CN1074670C (en) 1998-01-23 1998-01-23 Medicine for the treatment of rheumatism and arthritis

Country Status (1)

Country Link
CN (1) CN1074670C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656352A (en) * 2013-12-19 2014-03-26 孙斌 Traditional Chinese medicine for treating arthritis caused by heavy dampness
CN104173430A (en) * 2014-08-14 2014-12-03 胡友元 Traditional Chinese medicine composition for treating rheumatism and preparation method of traditional Chinese medicine composition
CN106902207A (en) * 2015-12-18 2017-06-30 上海中医药大学附属龙华医院 Treat compound preparation of rheumatoid arthritis and preparation method thereof
CN109106916A (en) * 2018-10-31 2019-01-01 成都体育学院 A kind of Chinese medicine composition and preparation method thereof for treating rheumatic arthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030963C (en) * 1993-02-25 1996-02-14 韦克仪 "Bitong" medicine liquid for external use
CN1055441C (en) * 1994-12-24 2000-08-16 李秀武 Foldable bicycle handlebar

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656352A (en) * 2013-12-19 2014-03-26 孙斌 Traditional Chinese medicine for treating arthritis caused by heavy dampness
CN103656352B (en) * 2013-12-19 2015-12-02 烟台倍生商贸有限公司 One treats the arthritic Chinese medicine of weight in wet base type
CN104173430A (en) * 2014-08-14 2014-12-03 胡友元 Traditional Chinese medicine composition for treating rheumatism and preparation method of traditional Chinese medicine composition
CN106902207A (en) * 2015-12-18 2017-06-30 上海中医药大学附属龙华医院 Treat compound preparation of rheumatoid arthritis and preparation method thereof
CN109106916A (en) * 2018-10-31 2019-01-01 成都体育学院 A kind of Chinese medicine composition and preparation method thereof for treating rheumatic arthritis
CN109106916B (en) * 2018-10-31 2021-06-11 成都体育学院 A Chinese medicinal composition for treating rheumatic arthritis, and preparation method thereof

Also Published As

Publication number Publication date
CN1074670C (en) 2001-11-14

Similar Documents

Publication Publication Date Title
CN101972453B (en) Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof
CN101041046A (en) Chinese traditional medicine compound took orally for treating morning diarrhea
CN102247497A (en) Chinese patent medicine for treating rheumatoid arthritis
CN104491052A (en) Traditional Chinese medicine composition for treating rheumatic and rheumatoid arthritis and preparation method thereof
CN1074670C (en) Medicine for the treatment of rheumatism and arthritis
CN1184989C (en) Weight-reducing Chinese medicine acted on acupoint
CN102028831B (en) Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof
CN1181878C (en) Detumescence plaster
CN1846756A (en) Amber bolus
CN1049598C (en) Chinese medicine prepn for psoriasis and its prepn
CN1179736C (en) Chinese medicine for curing gastropathy
CN111419924A (en) A topical Chinese medicinal composition for treating various muscle and bone diseases, and its preparation device
CN104940630A (en) Traditional Chinese medicine composition for treating qi and blood deficiency type menstrual body pain
CN1177606C (en) Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process
CN101032546A (en) Medicine for dunking tendon
CN104524080A (en) Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method
CN1229118C (en) Bone setting medicine
CN100335082C (en) Medicine for treating rheumarthritis
CN1162163C (en) Chinese herbal medicinal liquor for curing rheumatic arthritis
CN1180808C (en) Chinese medicine for treating rheumatic and rheumatoid diseases
CN1404850A (en) Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine
CN1911357A (en) Medicinal composition for treating hyperosteogency
CN101028352A (en) Chinese-medicinal preparation for treating ischiodynia
CN1235840A (en) Chinese medicine powder for curing rheumatoid and rheumatic diseases
CN1171967A (en) Medicinal liquid Yuyepizhengke for curing rheumatic arthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee